Inverse effects of the PPARγ2 Pro12Ala polymorphism on measures of adiposity over 15 years in African Americans and whites. The CARDIA study
- 31 July 2005
- journal article
- Published by Elsevier in Metabolism
- Vol. 54 (7) , 910-917
- https://doi.org/10.1016/j.metabol.2005.02.005
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Effect of the peroxisome proliferator activated receptor- gene Pro12Ala variant on body mass index: a meta-analysisJournal of Medical Genetics, 2003
- Interaction between a peroxisome proliferator-activated receptor gene polymorphism and dietary fat intake in relation to body massHuman Molecular Genetics, 2003
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- The PPARγ2 Polymorphism Pro12Ala is Associated with Better Insulin Sensitivity in the Offspring of Type 2 Diabetic PatientsHormone and Metabolic Research, 2000
- The Pro12Ala Polymorphism in PPAR γ2 May Confer Resistance to Type 2 DiabetesBiochemical and Biophysical Research Communications, 2000
- Pro12Ala Missense Mutation of the Peroxisome Proliferator Activated Receptor γ and Diabetes MellitusBiochemical and Biophysical Research Communications, 1999
- PPARγ3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoterFEBS Letters, 1998
- Molecular Scanning of the Human Peroxisome Proliferator Activated Receptor γ (hPPARγ) Gene in Diabetic Caucasians: Identification of a Pro12Ala PPARγ2 Missense MutationBiochemical and Biophysical Research Communications, 1997
- Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.Journal of Clinical Investigation, 1997
- Cardia: study design, recruitment, and some characteristics of the examined subjectsJournal of Clinical Epidemiology, 1988